These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

567 related items for PubMed ID: 24789622

  • 1. Combined intravitreal melphalan and topotecan for refractory or recurrent vitreous seeding from retinoblastoma.
    Ghassemi F, Shields CL, Ghadimi H, Khodabandeh A, Roohipoor R.
    JAMA Ophthalmol; 2014 Aug; 132(8):936-41. PubMed ID: 24789622
    [Abstract] [Full Text] [Related]

  • 2. Intravitreal melphalan for persistent or recurrent retinoblastoma vitreous seeds: preliminary results.
    Shields CL, Manjandavida FP, Arepalli S, Kaliki S, Lally SE, Shields JA.
    JAMA Ophthalmol; 2014 Mar; 132(3):319-25. PubMed ID: 24407202
    [Abstract] [Full Text] [Related]

  • 3. INTRAVITREOUS CHEMOTHERAPY FOR ACTIVE VITREOUS SEEDING FROM RETINOBLASTOMA: Outcomes After 192 Consecutive Injections. The 2015 Howard Naquin Lecture.
    Shields CL, Douglass AM, Beggache M, Say EA, Shields JA.
    Retina; 2016 Jun; 36(6):1184-90. PubMed ID: 26630319
    [Abstract] [Full Text] [Related]

  • 4. Rescue intra-arterial chemotherapy following retinoblastoma recurrence after initial intra-arterial chemotherapy.
    Shields CL, Say EA, Pointdujour-Lim R, Cao C, Jabbour PM, Shields JA.
    J Fr Ophtalmol; 2015 Jun; 38(6):542-9. PubMed ID: 25982423
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Combined intravitreal melphalan and intravenous/intra-arterial chemotherapy for retinoblastoma with vitreous seeds.
    Lee JH, Han JW, Hahn SM, Lyu CJ, Kim DJ, Lee SC.
    Graefes Arch Clin Exp Ophthalmol; 2016 Feb; 254(2):391-4. PubMed ID: 26511530
    [Abstract] [Full Text] [Related]

  • 8. Intravitreal topotecan in the management of refractory and recurrent vitreous seeds in retinoblastoma.
    Rao R, Honavar SG, Sharma V, Reddy VAP.
    Br J Ophthalmol; 2018 Apr; 102(4):490-495. PubMed ID: 28844050
    [Abstract] [Full Text] [Related]

  • 9. Retinoblastoma Control With Primary Intra-arterial Chemotherapy: Outcomes Before and During the Intravitreal Chemotherapy Era.
    Shields CL, Alset AE, Say EA, Caywood E, Jabbour P, Shields JA.
    J Pediatr Ophthalmol Strabismus; 2016 Sep 01; 53(5):275-84. PubMed ID: 27486728
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Alternated intra-arterial and intravitreal chemotherapy for advanced intraocular retinoblastoma: preliminary successful results without systemic chemotherapy.
    De Francesco S, Galluzzi P, Bracco S, Menicacci F, Motolese E, Hadjistilianou T.
    Int Ophthalmol; 2015 Dec 01; 35(6):887-95. PubMed ID: 26416040
    [Abstract] [Full Text] [Related]

  • 12. Intravitreal chemotherapy in the management of vitreous disease in retinoblastoma.
    Kiratli H, Koç İ, Varan A, Akyüz C.
    Eur J Ophthalmol; 2017 Jun 26; 27(4):423-427. PubMed ID: 28106239
    [Abstract] [Full Text] [Related]

  • 13. Intravitreal Lower-Dose (20 µg) Melphalan for Persistent or Recurrent Retinoblastoma Vitreous Seeds.
    Tuncer S, Balcı Ö, Tanyıldız B, Kebudi R, Shields CL.
    Ophthalmic Surg Lasers Imaging Retina; 2015 Oct 26; 46(9):942-8. PubMed ID: 26469234
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Intravitreal Topotecan for Vitreous Seeds in Retinoblastoma: A Long-term Review of 91 Eyes.
    Sen M, Rao R, Mulay K, Reddy VAP, Honavar SG.
    Ophthalmology; 2024 Oct 26; 131(10):1215-1224. PubMed ID: 38703794
    [Abstract] [Full Text] [Related]

  • 16. Intra-arterial chemotherapy for retinoblastoma in 70 eyes: outcomes based on the international classification of retinoblastoma.
    Shields CL, Manjandavida FP, Lally SE, Pieretti G, Arepalli SA, Caywood EH, Jabbour P, Shields JA.
    Ophthalmology; 2014 Jul 26; 121(7):1453-60. PubMed ID: 24656794
    [Abstract] [Full Text] [Related]

  • 17. [Short-term efficacy of intravitreal injection of melphalan for refractory vitreous seeding from retinoblastoma].
    Xue K, Ren H, Zhang R, Yuan YF, Qian J.
    Zhonghua Yan Ke Za Zhi; 2017 Aug 11; 53(8):570-574. PubMed ID: 28851196
    [Abstract] [Full Text] [Related]

  • 18. Diffuse chorioretinal atrophy after a single standard low- dose intravitreal melphalan injection in a child with retinoblastoma: a case report.
    Chao A, Kao LY, Liu L, Wang NK.
    BMC Ophthalmol; 2016 Mar 15; 16():27. PubMed ID: 26975871
    [Abstract] [Full Text] [Related]

  • 19. Minimal exposure (one or two cycles) of intra-arterial chemotherapy in the management of retinoblastoma.
    Shields CL, Kaliki S, Shah SU, Bianciotto CG, Liu D, Jabbour P, Griffin GC, Shields JA.
    Ophthalmology; 2012 Jan 15; 119(1):188-92. PubMed ID: 21975042
    [Abstract] [Full Text] [Related]

  • 20. Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indications.
    Munier FL, Gaillard MC, Balmer A, Soliman S, Podilsky G, Moulin AP, Beck-Popovic M.
    Br J Ophthalmol; 2012 Aug 15; 96(8):1078-83. PubMed ID: 22694968
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.